Oncolytics Biotech Inc. (ONC.TO)
| Previous Close | 1.5400 |
| Open | 1.5600 |
| Bid | 1.5800 x 0 |
| Ask | 1.5900 x 0 |
| Day's Range | 1.5500 - 1.5900 |
| 52 Week Range | 1.2000 - 4.4900 |
| Volume | |
| Avg. Volume | 84,385 |
| Market Cap | 119.917M |
| Beta (5Y Monthly) | 1.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4100 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.67 |
- Baystreet
Stocks in play: Oncolytics Biotech Inc
Announced that it will host a conference call and webcast on Thursday, May 9, at 4:30 p.m. ET to discuss ...
CNW GroupOncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it will host a conference call and webcast on Thursday, May 9, 2024, at 4:30 p.m. ET to discuss a corporate update and financial results for the first quarter 2024.
CNW GroupOncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the acceptance of two abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place from May 31 – June 4, 2024, in Chicago, Illinois. Details on the abstracts and poster presentation are shown below.
